… as top priorities for new vaccine development. In five out of six WHO regions, annual child deaths and contribution to antimicrobial resistance were the most heavily weighted criteria. “Too often global decisions on new vaccines have been solely driven by …

… has been approved in Canada to prevent lower respiratory tract disease caused by respiratory syncytial virus (RSV) in adults 50-59 years of age at increased risk for RSV disease. In Canada, the vaccine was previously approved for use in adults aged 60 and …

… influenza vaccine, also within the framework of the vaccination campaign against COVID-19 this season, and expressed that “nothing was felt.” Health workers attended the Treasury room to vaccinate Sheinbaum Pardo, at the end of her morning conference this …

… that he wouldn't prioritize the research, manufacturing or distribution of shots if faced with another pandemic, falsely adding that "vaccines have probably caused more deaths than they've averted." Kennedy's track record as a vaccine …

… prevent serious infections caused by the virus. As a second option, pregnant people can protect their newborns from RSV by getting Abrysvo® (RSVpreF vaccine) during pregnancy. RSV is a common respiratory virus that can cause severe infections, particularly …

… the most successful medical interventions of the 20th century. In fact, many people haven’t even heard of Rh disease — red blood cell incompatibility between mother and child — which once killed about 10,000 newborns a year in the U.S., because a vaccine …